While the November 27, 2018 enforcement deadline for phase two of the Drug Supply Chain Security Act (DSCSA) is fast approaching, a new study conducted by not-for-profit information standards organization, GS1 US, suggests that the majority of pharmaceutical manufacturers aren’t yet compliant.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,